NFKB1 and chronic kidney disease: Resveratrol treatment (200 mg/kg*day for 21 days) prevented an increase in MuRF1 expression and attenuated muscle atrophy in the 5/6-nephrectomy mouse model of chronic kidney disease. Resveratrol also attenuated dexamethasone-induced MuRF1 expression in C2C12 myotubes possibly due to inhibition of NF-κB signaling.